Tiger Balm

Broker's Calls

Haw Par trading below historical book value, CGSI highlights in unrated report

Post Covid-19, FY2023 saw a rebound with the group's healthcare business revenue recovering to $213.5 million.
After more than a century, Haw Par continues to ride the Tiger and won’t get off - THE EDGE SINGAPORE

SGX Research Series: 10 in 10

After more than a century, Haw Par continues to ride the Tiger and won't get off

“Haw” and “Par” means “tiger” and “leopard”, respectively in Hokkien.


Haw Par's roar muffles with a 19.1% drop in earnings to $91.0 mil in 1H2020

Haw Par has recommended a first and interim dividend of 15 cents for the period, to be paid in September. The same amount was paid out in 1H2019.


Haw Par roars to 10.2% rise in 2Q earnings to $90.5 mil on continued demand for Tiger Balm

SINGAPORE (Aug 7): Haw Par Corporation saw its earnings grow 10.2% to $90.5 million for the 2Q19 ended June, from $82.1 million a year ago, on the back of higher operating profit and dividend income.


Haw Par posts 21.8% higher 1Q earnings of $17.3 mi on revenue growth

SINGAPORE (May 11): Haw Par Corp, the manufacturer of Tiger Balm ointment with interest in the leisure and property sectors, has announced 1Q17 earnings of $17.3 million, up 21.8% from the $14.2 million the year before.
Tiger Balm ointment

Haw Par posts 27% rise in 1Q earnings to $17.1 mil

SINGAPORE (May 11): Tiger Balm ointment maker Haw Par Corp posted a 26.8% rise in 1Q earnings to $17.1 million from a year ago. This came on the back of a 14.9% rise in revenue to $52.3 million and a more than tripling of other income to $4.8 million.